Seeking Alpha

Science-Of-Aging

 
View as an RSS Feed
View Science-Of-Aging's Articles BY TICKER:
  • Osiris Therapeutics: Poised For Another Breakout
    Tue, Mar. 11 OSIR 22 Comments

    Summary

    • Osiris recently became profitable with impressive sales growth yet the market failed to react to this news.
    • Osiris's mature stem cell products have shown overwhelming efficacy and they have plenty of funds to market them.
    • Osiris presents tremendous value to the investor as the market has failed to account for sales growth and reduced R&D costs.
  • Osiris Therapeutics: Still The Best Bet In Regenerative Medicine
    Nov. 27, 2012 OSIR Comment!
  • Osiris Therapeutics: An Old Stem Cell Biotech Coming Of Age
    Jun. 29, 2012 OSIR 6 Comments